187 related articles for article (PubMed ID: 38612387)
1. A1CF Binding to the p65 Interaction Site on NKRF Decreased IFN-β Expression and p65 Phosphorylation (Ser536) in Renal Carcinoma Cells.
Liu Y; Yang J; Weng D; Xie Y
Int J Mol Sci; 2024 Mar; 25(7):. PubMed ID: 38612387
[TBL] [Abstract][Full Text] [Related]
2. A1CF-promoted colony formation and proliferation of RCC depends on DKK1-MEK/ERK signal axis.
Ni D; Yi Q; Liu J; Hu Y; Lv T; Tan G; Liu Y; Xu L; Xia H; Zhou Q; Xie Y
Gene; 2020 Mar; 730():144299. PubMed ID: 31881249
[TBL] [Abstract][Full Text] [Related]
3. APOBEC1 complementation factor facilitates cell migration by promoting nucleus translocation of SMAD3 in renal cell carcinoma cells.
Xia H; Liu Y; Xu L; Mao H; Zhou Q; Xie Y
In Vitro Cell Dev Biol Anim; 2021 May; 57(5):501-509. PubMed ID: 34002283
[TBL] [Abstract][Full Text] [Related]
4. Apobec-1 complementation factor regulates cell migration and apoptosis through Dickkopf1 by acting on its 3' untranslated region in MCF7 cells.
Yan X; Li Q; Ni D; Xie Y; He Q; Wan Q; Liu Y; Lyu Z; Mao Z; Zhou Q
Tumour Biol; 2017 Jun; 39(6):1010428317706218. PubMed ID: 28639893
[TBL] [Abstract][Full Text] [Related]
5. Apobec1 complementation factor (A1CF) and RBM47 interact in tissue-specific regulation of C to U RNA editing in mouse intestine and liver.
Blanc V; Xie Y; Kennedy S; Riordan JD; Rubin DC; Madison BB; Mills JC; Nadeau JH; Davidson NO
RNA; 2019 Jan; 25(1):70-81. PubMed ID: 30309881
[TBL] [Abstract][Full Text] [Related]
6. APOBEC1 complementation factor (A1CF) is dispensable for C-to-U RNA editing in vivo.
Snyder EM; McCarty C; Mehalow A; Svenson KL; Murray SA; Korstanje R; Braun RE
RNA; 2017 Apr; 23(4):457-465. PubMed ID: 28069890
[TBL] [Abstract][Full Text] [Related]
7. Parent-of-origin effects of A1CF and AGO2 on testicular germ-cell tumors, testicular abnormalities, and fertilization bias.
Carouge D; Blanc V; Knoblaugh SE; Hunter RJ; Davidson NO; Nadeau JH
Proc Natl Acad Sci U S A; 2016 Sep; 113(37):E5425-33. PubMed ID: 27582469
[TBL] [Abstract][Full Text] [Related]
8. Comparison of RNA Editing Activity of APOBEC1-A1CF and APOBEC1-RBM47 Complexes Reconstituted in HEK293T Cells.
Wolfe AD; Arnold DB; Chen XS
J Mol Biol; 2019 Mar; 431(7):1506-1517. PubMed ID: 30844405
[TBL] [Abstract][Full Text] [Related]
9. A phosphomimetic mutant of RelA/p65 at Ser536 induces apoptosis and senescence: An implication for tumor-suppressive role of Ser536 phosphorylation.
Bu Y; Li X; He Y; Huang C; Shen Y; Cao Y; Huang D; Cai C; Wang Y; Wang Z; Liao DF; Cao D
Int J Cancer; 2016 Mar; 138(5):1186-98. PubMed ID: 26375985
[TBL] [Abstract][Full Text] [Related]
10. High APOBEC1 Complementation Factor Expression Positively Modulates the Proliferation, Invasion, and Migration of Endometrial Cancer Cells Through Regulating P53/P21 Signaling Pathway.
Liu Q; Chen CY; Chen GL
Cancer Biother Radiopharm; 2022 Nov; 37(9):750-758. PubMed ID: 32818382
[No Abstract] [Full Text] [Related]
11. Inhibition of the aberrant A1CF-FAM224A-miR-590-3p-ZNF143 positive feedback loop attenuated malignant biological behaviors of glioma cells.
Song Y; Shao L; Xue Y; Ruan X; Liu X; Yang C; Zheng J; Shen S; Chen J; Li Z; Liu Y
J Exp Clin Cancer Res; 2019 Jun; 38(1):248. PubMed ID: 31186064
[TBL] [Abstract][Full Text] [Related]
12. A1CF-Axin2 signal axis regulates apoptosis and migration in Wilms tumor-derived cells through Wnt/β-catenin pathway.
Ni D; Liu J; Hu Y; Liu Y; Gu Y; Zhou Q; Xie Y
In Vitro Cell Dev Biol Anim; 2019 Apr; 55(4):252-259. PubMed ID: 30825095
[TBL] [Abstract][Full Text] [Related]
13. EIYMNVPV Motif is Essential for A1CF Nucleus Localization and A1CF (-8aa) Promotes Proliferation of MDA-MB-231 Cells via Up-Regulation of IL-6.
Zhou L; Hao J; Yuan Y; Peng R; Wang H; Ni D; Gu Y; Huang L; Mao Z; Lyu Z; Du Y; Liu Z; Li Y; Ju P; Long Y; Liu J; Zhou Q
Int J Mol Sci; 2016 May; 17(6):. PubMed ID: 27231908
[TBL] [Abstract][Full Text] [Related]
14. Identification of domains in apobec-1 complementation factor required for RNA binding and apolipoprotein-B mRNA editing.
Mehta A; Driscoll DM
RNA; 2002 Jan; 8(1):69-82. PubMed ID: 11871661
[TBL] [Abstract][Full Text] [Related]
15. Apobec1 complementation factor overexpression promotes hepatic steatosis, fibrosis, and hepatocellular cancer.
Blanc V; Riordan JD; Soleymanjahi S; Nadeau JH; Nalbantoglu I; Xie Y; Molitor EA; Madison BB; Brunt EM; Mills JC; Rubin DC; Ng IO; Ha Y; Roberts LR; Davidson NO
J Clin Invest; 2021 Jan; 131(1):. PubMed ID: 33445170
[TBL] [Abstract][Full Text] [Related]
16. STC1 promotes cell apoptosis via NF-κB phospho-P65 Ser536 in cervical cancer cells.
Pan X; Jiang B; Liu J; Ding J; Li Y; Sun R; Peng L; Qin C; Fang S; Li G
Oncotarget; 2017 Jul; 8(28):46249-46261. PubMed ID: 28545028
[TBL] [Abstract][Full Text] [Related]
17. C to U RNA editing mediated by APOBEC1 requires RNA-binding protein RBM47.
Fossat N; Tourle K; Radziewic T; Barratt K; Liebhold D; Studdert JB; Power M; Jones V; Loebel DA; Tam PP
EMBO Rep; 2014 Aug; 15(8):903-10. PubMed ID: 24916387
[TBL] [Abstract][Full Text] [Related]
18. Ubiquitin-specific peptidase 53 inhibits the occurrence and development of clear cell renal cell carcinoma through NF-κB pathway inactivation.
Gui D; Dong Z; Peng W; Jiang W; Huang G; Liu G; Ye Z; Wang Y; Xu Z; Fu J; Luo S; Zhao Y
Cancer Med; 2021 Jun; 10(11):3674-3688. PubMed ID: 33973730
[TBL] [Abstract][Full Text] [Related]
19. Targeting NF-κB RelA/p65 phosphorylation overcomes RITA resistance.
Bu Y; Cai G; Shen Y; Huang C; Zeng X; Cao Y; Cai C; Wang Y; Huang D; Liao DF; Cao D
Cancer Lett; 2016 Dec; 383(2):261-271. PubMed ID: 27721021
[TBL] [Abstract][Full Text] [Related]
20. Phosphorylation of NF-κBp65 drives inflammation-mediated hepatocellular carcinogenesis and is a novel therapeutic target.
Xu X; Lei Y; Chen L; Zhou H; Liu H; Jiang J; Yang Y; Wu B
J Exp Clin Cancer Res; 2021 Aug; 40(1):253. PubMed ID: 34380537
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
